August 8, 2011

The Food and Drug Administration has accepted an approval application for a drug made by Teva Pharmaceutical Industries for treating allergies, Teva said.

August 8, 2011

An investigational treatment made by Roche for asthma increased lung function in patients who could not adequately control their disease with inhaled corticosteroids, according to results of a mid-stage clinical trial.

August 2, 2011

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

July 29, 2011

Researchers have found a human antibody that may be able to protect against all influenza A viruses, according to published reports.

May 31, 2011

Researchers at Children's Hospital Boston have discovered the reason why influenza may induce asthma attacks among children.

May 25, 2011

Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

May 17, 2011

An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

May 11, 2011

Drug maker Perrigo has reached a licensing agreement with Nycomed US that will allow it to launch a generic treatment for dermatitis in 2012, the company said.

May 10, 2011

Patients with seasonal allergies are more likely to experience difficulty sleeping, according to results of a new survey conducted by Teva Respiratory.

April 22, 2011

The Centers for Disease Control and Prevention on Thursday announced its CDC Flu App Challenge to identify innovative and creative uses of technology that would help raise awareness of influenza and/or educate consumers on ways to prevent and treat the flu. All told, the challenge will award up to $42,500 in prizes.

April 20, 2011

Lysol, a Reckitt Benckiser brand, is looking to help allergy sufferers this spring.

April 18, 2011

The Food and Drug Administration declined to approve a drug made by Eli Lilly for treating a disease of the pancreas that often occurs in patients with cystic fibrosis, Lilly said.

April 15, 2011

Whoever named the genus to which ragweed plants belong “ambrosia” had a terrific sense of irony. The name, derived from Greek, refers to the food of the gods, but the plant is more like punishment from the gods, considering that it’s the main culprit in seasonal allergies.

April 12, 2011

The 2011 allergy season is expected to be 27 days longer in the northernmost parts of North America, adding almost a month of suffering to the typical pollen allergy season of February through October, a study published Tuesday by the Proceedings of the National Academy of Sciences determined.

March 29, 2011

In a sneeze heard around the world, allergy season is afoot, but the country’s retail pharmacies are on call to help the estimated 60 million Americans whose sneezing, coughing, watery eyes and congestion will drive them to wit’s end this year.

March 24, 2011

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

March 22, 2011

Less than 20% of surveyed patients with nasal allergies find their symptoms are completely controlled over a one-week period of treatment, according to a survey performed by drug maker Teva Pharmaceutical Industries.

March 4, 2011

PLYMOUTH MEETING, Pa. — Pollen.com and Weather Trends International last month teamed together on a new forecast tool for allergy sufferers: a 28-day weather forecast by zip code to help people with allergies better plan when pollen levels are likely to be high in their area.

February 9, 2011

An investigational drug made by Teva Pharmaceutical Industries for treating allergies is safe and effective, according to results of a late-stage clinical trial announced Wednesday.

January 27, 2011

Seniors of Hispanic descent are far less likely to become immunized against the flu or pneumonia, compared with white seniors, according to a new RAND study released earlier this week.

January 24, 2011

As many as 71% of cough-cold sufferers in search of decongestant relief oppose a prescription requirement for pseudoephedrine, according to a survey commissioned by the Asthma and Allergy Foundation of America released Monday.

January 20, 2011

Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.

November 15, 2010

An investigative treatment for allergies made by Teva Pharmaceutical Industries appears to work, according to...

November 14, 2010

Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of...